| Date | Title | Description | Source |
| 20.11.2023 | Metabolon Collaborates with Trajan on Microsampling Solution... | The power of advanced metabolomic analytical techniques can now be applied to a broader array of div... | en.prnasia... |
| 25.01.2023 | Metabolon Raises $25M in Funding | Metabolon, a Morrisville, NC-based provider of metabolomics solutions that offers variety of researc... | finsmes.co... |
| 24.01.2023 | Metabolon Secures $25M |
MORRISVILLE, NC, Metabolon today announced that it has closed on $25 million of additional equity ... | vcnewsdail... |
| 24.01.2023 | Metabolon Secures $25 Million of Funding to Accelerate Growt... | MORRISVILLE, N.C, Jan. 24, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing meta... | en.prnasia... |
| 26.10.2021 | Demystifying the Microbiome: Connecting Metabolomics to Heal... | The unique capability of metabolomics to measure microbiome-derived metabolites sheds light on the b... | prweb.com/... |
| 23.09.2020 | Metabolon Announces $72 Million in Debt and Equity Financing | Metabolon, Inc., the global leader in metabolomics solutions advancing drug development and precisio... | citybizlis... |
| 23.09.2020 | Metabolon, Inc. : Announces $72 Million in Debt and Equity F... | MORRISVILLE, N.C., Sept. 23, 2020 /PRNewswire/ -- Metabolon, Inc., the global leader in metabolomics... | marketscre... |
| 23.09.2020 | Metabolon Closes $72 Million in Debt and Equity Financing | Metabolon, Inc., the global leader in metabolomics solutions advancing drug development and precisio... | citybizlis... |
| 11.10.2019 | Zosano Pharma CEO passes baton down to successor; James... | Steven Lo
→ Two years after Zosano Pharma reported positive Phase III data for its micronee... | endpts.com... |
| 08.12.2016 | Metabolon Raises Additional $15M |
RESEARCH TRIANGLE PARK, NC, Global leader in metabolomics, announced today that it has raised an a... | vcnewsdail... |
| 07.12.2016 | Term Sheet — Wednesday, December 7 | ET CETERA
• Adroll has laid off around 50 employees. AdRoll CEO Aaron Bell provided the following st... | fortune.co... |
| 06.12.2016 | Metabolon Raises Additional $15M in Funding | Metabolon, Inc., a Research Triangle Park, N.C.-based health technology company, raised an additiona... | finsmes.co... |
| 05.12.2016 | Metabolon Raises Additional $15 Million in Funding from Esse... | Dec 05 2016
RESEARCH TRIANGLE PARK, N.C. – – Metabolon, Inc., the global leader in metabolomics, an... | ewhealthca... |
| 05.12.2016 | Metabolon Raises Additional $15 Million in Funding From Esse... | RESEARCH TRIANGLE PARK, N.C., Dec. 05, 2016 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader i... | citybizlis... |
| 15.10.2016 | Beyond Theranos: Next options for a better blood draw | Theranos, once Silicon Valley’s sexiest startup, recently announced plans to shut down its blood-tes... | venturebea... |
| 12.08.2016 | Precision Medicine Company Metabolon Closes $15M Financing | Metabolon, Inc., a Research Triangle Park, N.C. – based global leader in metabolomics, raised $15m i... | finsmes.co... |
| 11.08.2016 | Metabolon Closes $15 Million Financing to Support Precision ... | Aug 11 2016
RESEARCH TRIANGLE PARK, N.C. –– Metabolon, Inc., the global leader in metabolomics, ann... | ewhealthca... |
| 07.07.2015 | Morning Read: BioCardia files IPO with hopes of $50M, HHS se... | In response to the influx of Central American children immigrating to the U.S. over the last year, t... | medcitynew... |
| 12.03.2015 | Metabolon raises $5M for tech that can determine how individ... | It is backed by roughly $50 million in private funding, including from Aurora Funds Inc., Fletcher S... | medcitynew... |
| 06.01.2014 | Metabolon Raises $15M in Series E Financing | Metabolon, Inc., a Durham, NC-based provider of metabolomics-based diagnostic tests and research ser... | finsmes.co... |
| 18.04.2012 | Takeda partners with Metabolon to find biomarkers for pharma... | Metabolon’s platform technology discovers biomarkers, chemical signatures that indicate disease. Ide... | medcitynew... |
| 12.04.2012 | Personalized medicine: A long path, uncertain directions and... | If personalized medicine’s promise isn’t easily understood, Dr. Kristin Newby can readily explain it... | medcitynew... |
| 15.02.2012 | Pharmas, medical device makers set to pitch at CED Life Scie... | A total of 16 companies are scheduled to make presentations, split evenly between pharmaceuticals an... | medcitynew... |
| 30.08.2011 | Metabolon Inks $13.1M Series D |
New investor Keating Capital, Inc. joins existing investors including Sevin Rosen Funds, Aurora Fu... | vcnewsdail... |
| 29.08.2011 | Metabolon Secures $13.1M in Series D Financing | Metabolon, Inc., a Durham, NC-based diagnostics and services company offering a biochemical profilin... | finsmes.co... |
| 29.08.2011 | Diagnostics firm Metabolon raises $13M in series D; is IPO n... | “We’re very impressed with Metabolon’s disruptive technology and commercial success,” Keating Capita... | medcitynew... |
| - | Morning Read: BioCardia files IPO with hopes of $50M, HHS se... | TOP STORIES
BioCardia, which is expecting to enter its lead cell-based therapy for cardiovascular di... | medcitynew... |
| - | Metabolon raises $5M for tech that can determine how individ... | Metabolomics company Metabolon just raised about $5 million in equity from four investors, according... | medcitynew... |
| - | Personalized medicine: A long path, uncertain directions and... | If personalized medicine’s promise isn’t easily understood, Dr. Kristin Newby can readily explain it... | medcitynew... |
| - | Diagnostics firm Metabolon raises $13M in series D; is IPO n... | Diagnostics firm Metabolon has raised $13.1 million in a fourth round of financing and in doing so h... | medcitynew... |
| - | Metabolon | “Metabolon uses metabolomics to provide biological insights to answer the toughest questions in life... | fastfounde... |
| - | Pharmas, medical device makers set to pitch at CED Life Scie... | Life science companies and investors, let’s make a deal.
The annual CED Life Science Conference kick... | medcitynew... |
| - | Takeda partners with Metabolon to find biomarkers for pharma... | Takeda Pharmaceutical (TYO:4502) will use biochemical discovery technology from Metabolon to find ne... | medcitynew... |
